Oddo BHF Asset Management Sas acquired a new stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund acquired 377,500 shares of the biotechnology company’s stock, valued at approximately $27,229,000. Avidity Biosciences accounts for approximately 1.0% of Oddo BHF Asset Management Sas’ portfolio, making the […]

Athos Capital Ltd purchased a new stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 184,564 shares of the biotechnology company’s stock, valued at approximately $13,313,000. Avidity Biosciences makes up 5.1% of Athos Capital Ltd’s investment […]